Osteoporosis drug proves effective against breast cancer
Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show the drug raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased risk of the disease.